10-13-2010, SCHOTT North America
UltraSafe Passive® technology from Safety Syringes, Inc. is now available for SCHOTT InJentle™ – the Innovative Staked Needle Syringe for Sensitive Drugs
SCHOTT InJentle™ is a completely unique packaging solution for the pharmaceutical industry. It offers a number of novel features for the benefit of highly sensitive drugs, in particular. Its unique design stands for improved drug stability, gentle application and also the flexibility to include further anti-counterfeiting features (e.g. RFID).
“The drug doesn’t come into contact with the needle during storage,” says Carmen Heiter, Product Manager for Syringes at SCHOTT. “This prevents sensitive drugs from interacting with the adhesive or the metal of the needle.” A robust tamper-evident closure is integrated in the unique design of the syringe. As soon as the system is opened, this part will break and cannot be reconnected. This allows physicians or patients to determine whether or not a syringe has already been used.
Because of the unique design of “SCHOTT InJentle”, the needle point is fully protected and does not touch the needle shield or any other material. This guarantees best needle lubrication and straight needles; hooks are avoided. The syringe is completely tungsten-free and allows for the use of particularly thin needles of up to 31 gauge which results in a reduction of pain for the patients during injection.
Innovation doesn’t stop here: To offer effective needlestick protection for healthcare professionals, a special protective needle safety mechanism that shields the needle immediately after injection has now been developed by SSI. Its added handling benefits are obvious. A wider plunger head, finger flanges and a rounded body design offer qualified personnel safe support, and no special procedures are necessary to put the syringes into operation.
“The UltraSafe Passive safety mechanism shields the needle automatically right after injection which is a key requirement for effective needlestick protection, as a large portion of needlestick injuries happen after injection when the bare needle is removed from the injection site.” says Alexander Jaksch, VP of Business Development & Marketing at Safety Syringes. One-handed operation is possible and no new injection technique is necessary. In addition, these syringes come pre-assembled in ready-to-use-packages.
About Safety Syringes, Inc. Safety Syringes, Inc. (SSI) is a privately-owned company founded in 1990. Since then, SSI has established itself as the market leader in safety devices for prefilled glass syringes and the preferred partner of the world’s leading pharmaceutical companies. With a strong core competency in needlestick safety devices for prefilled glass syringes, SSI will continue to lead the expanding prefilled syringe safety market with solutions that reduce the costs of meeting increasingly stringent global legislation. SSI is headquartered in Carlsbad, USA.
|Innovation||Products||Press||Careers||SCHOTT North America|